Background/Aims: In cirrhosis, the activation of nitric oxide and pros
tacyclin contributes to vasodilation, and ATP-sensitive K+ (K-ATP) cha
nnel activation or L-type calcium (Ca2+) channel inhibition may also p
lay a role in this process. At the same time in cirrhosis, certain end
ogenous mechanisms may be stimulated which limit the influence of vaso
dilator mechanisms on vascular tone, thus altering vascular responses
to exogenous substances such as nitric oxide donors, exogenous prostac
yclin, K-ATP channel openers or L-type Ca2+ channel blockers, The aim
of the present study was to examine the arterial depressor to these ex
ogenous substances in normal rats and in rats with secondary biliary c
irrhosis. Methods: Arterial depressor dose-response curves to nitropru
sside (a nitric oxide donor, 5-60 mu g . kg(-1) . min(-1)), prostacycl
in (0.5-5 mu g . kg(-1)) and aprikalim (a K-ATP channel opener, 10-200
mu g . kg(-1)) were obtained in both groups. The effects of different
L-type Ca2+ channel blockers, i.e. nicardipine (a dihydropyridine, 0.
02-0.5 mg . kg(-1)), diltiazem (a benzothiazepine, 0.5-5 mg . kg(-1))
and verapamil (a phenylalkylamine, 0.02-0.2 mg . kg(-1) . min(-1)), we
re also studied. Results: Cirrhosis produced hyporeactivity to the art
erial depressor effect of all doses of nitroprusside, the lowest dose
of prostacyclin and the highest doses of aprikalim or diltiazem. Cirrh
osis did not significantly change depressor responses to nicardipine o
r verapamil. Conclusions: Rats with cirrhosis are hyporeactive to exog
enous nitric oxide, prostacyclin, K-ATP channel opener and benzothiaze
pine (an L-type Ca2+ channel blocker). Therefore, cirrhosis-induced me
chanisms seem to limit the decrease in vascular tone by most vasodilat
ors. However, these mechanisms appear to be more marked in nitric oxid
e-mediated vasodilation than in other vasorelaxation mechanisms.